Abstract
PAPA syndrome (Pyogenic Arthritis, Pyoderma gangrenosum, and Acne) is an autosomal dominant, hereditary auto-inflammatory disease arising from mutations in the PSTPIP1/CD2BP1 gene on chromosome 15q. These mutations produce a hyper-phosphorylated PSTPIP1 protein and alter its participation in activation of the “inflammasome” involved in interleukin-1 (IL-1β) production. Overproduction of IL-1β is a clear molecular feature of PAPA syndrome. Ongoing research is implicating other biochemical pathways that may be relevant to the distinct pyogenic inflammation of the skin and joints characteristic of this disease. This review summarizes the recent and rapidly accumulating knowledge on these molecular aspects of PAPA syndrome and related disorders.
Keywords: Auto-inflammatory disease, PAPA syndrome, PSTPIP1, CD2BP1, PTP-PEST, pyrin, neutrophils, microarray transcript profiling, anakinra, IL-1β, disease, syndrome, microarray, (FMF), (TRAPS), (HIDS), (FCAS), (MWS), (NOMID), (DIRA), (CGD), Mutation Screening, arthritis, (IL-1), (TNF), CD2, CCTG, PSTPIP2, CRMO, WASP, HSCF, LPS, PBMCs, SoJIA, SLE, IL 1-β
Current Genomics
Title: Clinical, Molecular, and Genetic Characteristics of PAPA Syndrome: A Review
Volume: 11 Issue: 7
Author(s): Elisabeth J. Smith, Florence Allantaz, Lynda Bennett, Dongping Zhang, Xiaochong Gao, Geryl Wood, Daniel L. Kastner, Marilynn Punaro, Ivona Aksentijevich, Virginia Pascual and Carol A. Wise
Affiliation:
Keywords: Auto-inflammatory disease, PAPA syndrome, PSTPIP1, CD2BP1, PTP-PEST, pyrin, neutrophils, microarray transcript profiling, anakinra, IL-1β, disease, syndrome, microarray, (FMF), (TRAPS), (HIDS), (FCAS), (MWS), (NOMID), (DIRA), (CGD), Mutation Screening, arthritis, (IL-1), (TNF), CD2, CCTG, PSTPIP2, CRMO, WASP, HSCF, LPS, PBMCs, SoJIA, SLE, IL 1-β
Abstract: PAPA syndrome (Pyogenic Arthritis, Pyoderma gangrenosum, and Acne) is an autosomal dominant, hereditary auto-inflammatory disease arising from mutations in the PSTPIP1/CD2BP1 gene on chromosome 15q. These mutations produce a hyper-phosphorylated PSTPIP1 protein and alter its participation in activation of the “inflammasome” involved in interleukin-1 (IL-1β) production. Overproduction of IL-1β is a clear molecular feature of PAPA syndrome. Ongoing research is implicating other biochemical pathways that may be relevant to the distinct pyogenic inflammation of the skin and joints characteristic of this disease. This review summarizes the recent and rapidly accumulating knowledge on these molecular aspects of PAPA syndrome and related disorders.
Export Options
About this article
Cite this article as:
J. Smith Elisabeth, Allantaz Florence, Bennett Lynda, Zhang Dongping, Gao Xiaochong, Wood Geryl, L. Kastner Daniel, Punaro Marilynn, Aksentijevich Ivona, Pascual Virginia and A. Wise Carol, Clinical, Molecular, and Genetic Characteristics of PAPA Syndrome: A Review, Current Genomics 2010; 11 (7) . https://dx.doi.org/10.2174/138920210793175921
DOI https://dx.doi.org/10.2174/138920210793175921 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Geriatric Depression - Review for Primary Care
Current Psychiatry Reviews Development and Clinical use of Prasugrel and Ticagrelor
Current Pharmaceutical Design HIF Prolyl-4-hydroxylase Interacting Proteins: Consequences for Drug Targeting
Current Pharmaceutical Design Recent Advances in Targeted Anti-Vasculature Therapy: The Neuroblastoma Model
Current Drug Targets Mechanisms of Brain Signaling During Sepsis
Current Neuropharmacology Impact of Metabolic Surgery on Type-2 Diabetes Remission
Current Diabetes Reviews Glucose Blood Levels as a Therapeutic Target in Acute Ischaemic Stroke Setting
Current Topics in Medicinal Chemistry Membrane Lipids in the Function of Serotonin and Adrenergic Receptors
Current Medicinal Chemistry Atrial Tachycardias Occurring Late After Open Heart Surgery
Current Cardiology Reviews Reactive Oxygen Species: Physiological Roles in the Regulation of Vascular Cells
Current Molecular Medicine The Renin-Angiotensin System: The Role of Inhibitors, Blockers, and Genetic Polymorphisms in the Treatment and Prevention of Heart Failure
Current Vascular Pharmacology Orthostatic Hypotension: Evaluation and Treatment
Cardiovascular & Hematological Disorders-Drug Targets Molecular Genetics and Targeted Therapy in Hepatocellular Carcinoma
Current Cancer Drug Targets Exploring Molecular Approaches in Amyotrophic Lateral Sclerosis: Drug Targets from Clinical and Pre-Clinical Findings
Current Molecular Pharmacology Role of Antioxidants for the Treatment of Cardiovascular Diseases: Challenges and Opportunities
Current Pharmaceutical Design Control of Autoimmune Diseases by the B7-CD28 Family Molecules
Current Pharmaceutical Design The Roles of MicroRNAs in Atherosclerosis
Current Medicinal Chemistry SCIENTIFIC PAPERS
Adolescent Psychiatry Human Embryonic and Induced Pluripotent Stem Cells in Cardiovascular Drug Discovery: Patents and Patented Uses
Recent Patents on Cardiovascular Drug Discovery Rheumatoid Arthritis, Immunosenescence and the Hallmarks of Aging
Current Aging Science